Search Results - James Thom

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

    Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy by Tim Illidge, M. Bayne, Nicholas Brown, S. Chilton, Mark S. Cragg, Martin J. Glennie, Yong Du, Valerie Lewington, James Smart, James Thom, Maureen A. Zivanovic, Peter Johnson

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: